Business Context and Reporting Period
This Form 8-K is a current report filed by OncoCyte Corporation (not Insight Molecular Diagnostics Inc.) on February 22, 2021, covering events occurring on February 18, 2021. The registrant is incorporated in California and trades under the symbol OCX on the NYSE American. The filing serves as a Regulation FD disclosure regarding a virtual Fireside Chat with Diagnostics Analyst Mark Massaro at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a conference participation and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces the availability of a webcast recording of a conference presentation.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing includes a standard disclaimer that statements containing words such as "may," "will," "believes," or "expects" are forward-looking and subject to risks and uncertainties.
- Risk Factors: Investors are directed to the company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for a detailed discussion of risk factors that could cause actual results to differ materially from anticipated results.
- Management Commentary: Specific commentary is contained within the referenced webcast, which is deemed "furnished" and not "filed" under the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is OncoCyte Corporation, as the input metadata incorrectly referenced "Insight Molecular Diagnostics Inc."
- Access the webcast at www.oncocyte.com or the provided BTIG link to review the actual management commentary and any potential guidance discussed during the Fireside Chat.
- Review the most recent Form 10-K and 10-Q filings for actual financial metrics and detailed risk factors, as this 8-K does not contain them.
- Confirm the trading symbol OCX on the NYSE American exchange.